World Glial-Derived Neurotrophic Factor (GDNF) Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Glial-Derived Neurotrophic Factor (GDNF) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Glial-Derived Neurotrophic Factor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glial-Derived Neurotrophic Factor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Glial-Derived Neurotrophic Factor Overview
  3. Therapeutics Development
  4. Pipeline Products for Glial-Derived Neurotrophic Factor - Overview
  5. Pipeline Products for Glial-Derived Neurotrophic Factor - Comparative Analysis
  6. Glial-Derived Neurotrophic Factor - Therapeutics under Development by Companies
  7. Glial-Derived Neurotrophic Factor - Therapeutics under Investigation by Universities/Institutes
  8. Glial-Derived Neurotrophic Factor Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Glial-Derived Neurotrophic Factor - Products under Development by Companies
  13. Glial-Derived Neurotrophic Factor - Products under Investigation by Universities/Institutes
  14. Glial-Derived Neurotrophic Factor - Companies Involved in Therapeutics Development
  • NsGene A/S
  • UniQure N.V.

For more information about this report visit http://www.researchandmarkets.com/research/9w8644/glialderived

Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716